Convatec

18-Mar-25

Corporate

Advanced Wound Care

Convatec showcases its strongest wound care innovation pipeline ever at EWMA

Convatec will highlight key findings and the latest developments designed to deliver better healing outcomes

26-Feb-25

Corporate

Financial Performance

Annual results for the year ended 31 December 2024

Operational and strategic delivery drives double-digit adjusted EPS and cashflow growth

26-Jan-25

Corporate

Advanced Wound Care

Convatec welcomes the postponement of Local Coverage Determinations (LCDs) on skin substitutes in the United States

Healthcare professionals (HCPs) and patients have reported significant clinical benefits from the use of InnovaMatrix®.